These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8071009)

  • 1. An economic evaluation of the introduction of vaccination against hepatitis A in a peacekeeping operation. The case of the United Nations Protection Force in Yugoslavia.
    Jefferson T; Demicheli V; Wright D
    Int J Technol Assess Health Care; 1994; 10(3):490-7. PubMed ID: 8071009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should British soldiers be vaccinated against hepatitis A? An economic analysis.
    Jefferson TO; Behrens RH; Demicheli V
    Vaccine; 1994 Nov; 12(15):1379-83. PubMed ID: 7887014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of hepatitis A vaccination in Dutch military personnel.
    Buma AH; Beutels P; van Damme P; Tormans G; van Doorslaer E; Leentvaar-Kuijpers A
    Mil Med; 1998 Aug; 163(8):564-7. PubMed ID: 9715622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A in Norwegian troops.
    Hesla PE
    Vaccine; 1992; 10 Suppl 1():S80-1. PubMed ID: 1476003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-benefit ratio of tick-borne encephalitis vaccination of French troops based in Kosovo].
    Desjeux G; Lemardeley P; Colin C; Pascal B; Labarère J
    Rev Epidemiol Sante Publique; 2001 Jun; 49(3):249-57. PubMed ID: 11427828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A vaccination by Havrix in the Czech U.N. Troops according to data of seroprevalence in 1991-1995.
    Beran J; Douda P; Prymula R; Gál P; Rychlý R; Splino M
    Cent Eur J Public Health; 1996 May; 4(2):87-90. PubMed ID: 8996717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
    Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
    Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico.
    Carlos F; Gómez JA; Anaya P; Romano-Mazzotti L
    Hum Vaccin Immunother; 2016; 12(1):52-63. PubMed ID: 26503702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates.
    Jacobs RJ; Margolis HS; Coleman PJ
    Arch Pediatr Adolesc Med; 2000 Aug; 154(8):763-70. PubMed ID: 10922271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluations of hepatitis A vaccination in middle-income countries.
    Suwantika AA; Yegenoglu S; Riewpaiboon A; Tu HA; Postma MJ
    Expert Rev Vaccines; 2013 Dec; 12(12):1479-94. PubMed ID: 24168129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity.
    Ginsber GM; Slater PE; Shouval D
    J Hepatol; 2001 Jan; 34(1):92-9. PubMed ID: 11211913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of hepatitis A prevention in travellers.
    Tormans G; Van Damme P; Van Doorslaer E
    Vaccine; 1992; 10 Suppl 1():S88-92. PubMed ID: 1335668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An economic evaluation of vaccination against hepatitis A for frequent travellers.
    Fenn P; McGuire A; Gray A
    J Infect; 1998 Jan; 36(1):17-22. PubMed ID: 9515663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
    Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
    Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-benefit analysis of vaccination against tick-borne encephalitis among French troops.
    Desjeux G; Galoisy-Guibal L; Colin C
    Pharmacoeconomics; 2005; 23(9):913-26. PubMed ID: 16153134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic models of hepatitis A virus immunization.
    O'Connor JB; Imperiale TF; Singer ME
    Hepatology; 1999 Jul; 30(1):343-5. PubMed ID: 10428627
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic models of hepatitis A virus immunization.
    Meltzer M; Messonnier ML
    Hepatology; 1999 Jul; 30(1):343; author reply 344-5. PubMed ID: 10428626
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost effectiveness of hepatitis A virus immunisation in Spain.
    Arnal JM; Frisas O; Garuz R; Antoñanzas F
    Pharmacoeconomics; 1997 Sep; 12(3):361-73. PubMed ID: 10170461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.